Literature DB >> 3287560

Occurrence and pathogenicity of the Streptococcus milleri group.

J Gossling1.   

Abstract

Streptococci of the milleri group are part of the normal flora of human mucous membranes. These streptococci have also been reported to be significant pathogens. Like other mucosal streptococci, they may cause infective endocarditis; unlike other mucosal streptococci, however, they have also been repeatedly associated (more frequently in men than in women) with serious suppurative infections. Evidence for the pathogenicity of the Streptococcus milleri group is scattered and mainly circumstantial. Although the organisms are found in a high proportion of certain suppurative infections, other bacteria are often present as well. Successful treatment of these infections with surgery and broad-spectrum antibiotics is not indicative of any specific etiology. Only a few attempts at the induction of experimental infections other than endocarditis have been effective. Further investigation is required to establish the pathogenicity and pathogenic mechanisms of the S. milleri group.

Entities:  

Mesh:

Year:  1988        PMID: 3287560     DOI: 10.1093/clinids/10.2.257

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  70 in total

1.  Macrorestriction fingerprinting of "Streptococcus milleri" group bacteria by pulsed-field gel electrophoresis.

Authors:  K L Bartie; M J Wilson; D W Williams; M A Lewis
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Horizontal transfer of segments of the 16S rRNA genes between species of the Streptococcus anginosus group.

Authors:  Leo M Schouls; Corrie S Schot; Jan A Jacobs
Journal:  J Bacteriol       Date:  2003-12       Impact factor: 3.490

Review 3.  Streptococcus milleri group: renewed interest in an elusive pathogen.

Authors:  S C Piscitelli; J Shwed; P Schreckenberger; L H Danziger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-06       Impact factor: 3.267

4.  A neurosurgical presentation of patent foramen ovale with atrial septal aneurysm.

Authors:  Katie Walsh; Chandrasekaran Kaliaperumal; Gerry Wyse; George Kaar
Journal:  BMJ Case Rep       Date:  2011-07-20

5.  Deep neck space abscesses of dental origin: the impact of Streptococcus group Milleri.

Authors:  Andrej Terzic; Paolo Scolozzi
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-11-17       Impact factor: 2.503

6.  Splenic abscess and multiple brain abscesses caused by Streptococcus intermedius in a young healthy man.

Authors:  Jepsin Maliyil; William Caire; Rajasree Nair; Debbie Bridges
Journal:  Proc (Bayl Univ Med Cent)       Date:  2011-07

7.  Sialidase activity of the "Streptococcus milleri group" and other viridans group streptococci.

Authors:  D Beighton; R A Whiley
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

8.  Intermedilysin, a novel cytotoxin specific for human cells secreted by Streptococcus intermedius UNS46 isolated from a human liver abscess.

Authors:  H Nagamune; C Ohnishi; A Katsuura; K Fushitani; R A Whiley; A Tsuji; Y Matsuda
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

9.  A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients.

Authors:  Christopher D Sibley; Michael D Parkins; Harvey R Rabin; Kangmin Duan; Jens C Norgaard; Michael G Surette
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-23       Impact factor: 11.205

10.  Prospective study of Streptococcus milleri hepatic abscess.

Authors:  J Corredoira; E Casariego; C Moreno; L Villanueva; J Varela; A Rodríguez; P Alonso; A Coira
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-08       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.